Delivery Order SPE2DB24D9131-SPE2DB25FXRT4
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, valued at $18,488.12. The delivery order, which carries no set-aside designation, is for Trikafta 100-50-75 mg/150 mg tablets, a prescription medication used in the treatment of cystic fibrosis. The order is scheduled for completion by August 27, 2025, with performance taking...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on September 18, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 19, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on September 17, 2025. The contract calls for the delivery of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units, with an ultimate completion date of September 18, 2025. This delivery order was issued without a set-aside designation and represents performance at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,474.02 on August 5, 2025, for the supply of Trikafta 50-25-37.5 mg/75 mg tablets (84-count units). The contract carries no set-aside designation and is set to be completed by August 6, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency responsible...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on July 28, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The order, which carries an ultimate completion date of July 29, 2025, represents a standard pharmaceutical supply transaction without set-aside designation. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $148,787.74 by the Defense Logistics Agency (DLA) on June 2, 2025. The delivery order, which is not subject to any set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. The place of performance is Park Ridge, Illinois, with an ultimate completion date of June 3, 2025. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,754.56 by the Defense Logistics Agency on September 11, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This award leverages DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $37,736.66 firm fixed-price delivery order (4570051166) by the Defense Logistics Agency on November 17, 2025, for Trikafta 100-50-75 mg/150 mg tablets. The delivery order carries an ultimate completion date of November 18, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRT4Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, for Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, valued at $18,488.12, represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract carries no set-aside designation and has an ultimate completion date of September 2, 2025, with performance to be fulfilled from the contractor's location in Park Ridge, Illinois. This delivery order falls within DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, supporting the Department of Defense healthcare system. The contractor holds a significant single-award IDC with the DLA valued at $499,999,999 through November 2026, which enables the agency to issue firm fixed-price delivery orders for an extensive range of pharmaceutical products supporting military health facilities worldwide. Trikafta, a cystic fibrosis treatment medication, represents the type of specialty pharmaceutical product within the contractor's comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables distributed to federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/29/25 |